Dr Omar Hamdy, MD is an expert in Oncology at Mansoura University (Egypt). As of November 2026, ScienceLeadR ranks Omar Hamdy in the top 1% of experts in Egypt for Thyroid Neoplasms, Breast Diseases and Breast Neoplasms. Omar Hamdy has authored 147 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 538 (community average: 125). How the SLR is computed.

LeadR Profile

Profile validated by the expert
Dr Omar Hamdy, MD Mansoura University Egypt
538 ScienceLeadR Reputation 538
Network Map

Oncology

Subspecialties: Surgery - Gynecology - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

Faculty of Medicine - Mansoura University

2016 - 2026

Mansoura University - Lecturer of surgical oncology

2018 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 147

Citations

Citations: 2 132 1st author: 35 Last author: 16 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clinical Outcomes and Prognostic Factors of Kaposi Sarcoma in a Non-Endemic Region: A Retrospective Cohort Study.
PMID 43026879 — radiotherapy, sarcoma, kaposi, lymph nodes, cohort studies, drug therapy, sarcoma, neoplasm metastasis, lymph, diagnosis, therapeutics, wounds and injuries, prognosis, chemotherapy
Cancers (Basel)20260
International Initiative on a Refined Staging System for Medullary Thyroid Cancer: A Multinational Multicenter Study.
PMID 42981561 — neoplasms, thyroid gland, thyroid neoplasms
J Clin Oncol Top journal20260
Postoperative Vasoactive Exposure Patterns and Outcomes After Non-Cardiac Surgery: A Prespecified Analysis of the SQUEEZE Cohort.
PMID 42860683 — mortality, anesthesiology, classification, kidney, length of stay, cluster analysis, postoperative period, therapeutics, hemodynamics, acute kidney injury, vasoconstrictor agents
Acta Anaesthesiol Scand20260
Biological fact versus technical artifact in ER negative PR positive breast cancer.
PMID 42616285 — breast neoplasms, neoplasms, breast
Discov Oncol20260
Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries.
PMID 42483900 — global health, emergencies, surgical procedures, operative, neoplasms, income, cohort studies, colorectal neoplasms
BJS Open20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 3
Phase 2 3
Phase 1 1
Phase 2/Phase 3 1

By status:

Completed 4
Unknown 3
Active not recruiting 1

By type:

Interventional 5
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 9

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients
NCT06176339 — breast neoplasms, paclitaxel, pentoxifylline, cyclophosphamide, doxorubicin, neoplasms, tablets, drug therapy, breast, therapeutics, chemotherapy, female
Phase 2Active not recruiting2023

LeadR Networks

Main global connection map